|Status : Published||Published On : Jul, 2021||Report Code : VRHC1252||Industry : Healthcare||Available Format :||Page : 150|
The Indian telemedicine market was about USD 0.91 billion in 2020 and is anticipated to be valued at 6.1 billion by 2027, registering a CAGR of 31% during the forecast period 2021-2027. The Indian healthcare industry is shifting from conventional in-person doctor-patient interaction to virtually-enabled remote consultations.
The COVID-19 pandemic has accelerated the growth of virtual care in the country which includes teleconsultation, teleradiology, telepathology, and e-pharmacy. The healthcare providers, such as hospitals and e-pharmacies, have integrated teleconsultation platforms and expanded their existing digital products. There is a steep growth in the teleconsultation and e-pharmacies platform as it is adopted by doctors and patients. This has resulted in a boom in the Indian telemedicine market. The rising smartphone and internet penetration in rural areas, awareness about the availability of virtual visits as an alternative to physical consultations, escalating number of chronic diseases along with the need for better pre-and post-operative care, and access to affordable home monitoring equipment are the factors that are propelling the growth of telemedicine market in India. Telemedicine is an excellent medium to provide medical help to those who lacked the chance to get help in person and also it is cost-effective and efficient.
Nevertheless, telemedicine is an advanced technology through which patients can be monitored from home, doctors can keep a track of their progress and intervene when needed, resulting in the growth of the Indian telemedicine market. Thus, healthcare is shifting from hospital to home and providing patients with 24/7 care via mobile phones. Covid-19 has impacted India in the most detrimental ways, the country now has an excellent opportunity to become a digital health leader.
Insight by Type
Based on type, the Indian telemedicine market is divided into hardware, software, and telemedicine consultation services. Hardware is further subdivided into communication and networking, medical devices, and other devices (telemedicine cart, PAT, kits). Of these segments, telemedicine consultation services dominate the Indian telemedicine market as 64% of the consumers are willing to adopt teleconsultation post-COVID-19 Telemedicine consultation services have the potential to add value to the patient-provider experience. It can become the next frontier to deal with a public health crisis and act as a pillar of patient care in the post-Covid world, thus boosting the Indian telemedicine market.
Insight by Modality
Based on modality, the Indian telemedicine market is segmented into real-time telemedicine, remote patient monitoring, store-and-forward practice, consultation between specialists and primary caregivers, medical imaging, and telemedicine networks. Real-time telemedicine is the fastest-growing segment in the Indian telemedicine market due to the shortage of hospital beds in the COVID-19 outburst and innovative technologies are providing health organizations to have access and decrease the burden on hospitals through real-time consultation with doctors via smartphones, tablets, laptops, or PCs. This will boost India’s telemedicine market.
Insight by Application
Based on application, the Indian telemedicine market is categorized into teleradiology, telepathology, telecardiology, telepsychiatry, teledermatology, and others. Teleradiology is anticipated to dominate the market during the forecast period. This is due to the advancement in S&F technology and the scarcity of radiologists in rural areas. There is also a need for telemedicine to understand behavioral health such as bipolar disorders, attention disorders, anxiety, and depression, especially during the COVID-19 pandemic, which will lead to the growth of the telepsychiatry segment. The telecardiology segment will have a faster growth due to the rapid adoption of remote monitoring devices and m-health apps for tracking heart and pulse rate.
Insight by End-User
Based on end-user, the Indian telemedicine market is bifurcated into healthcare facilities and homecare. The homecare segment is anticipated to have significant growth during the forecast period. Factors contributing to the growth are cost-savings in healthcare service expenditure, increase in the geriatric population, use of telemonitoring to eliminate the risk of visiting hospitals in the COVID-19 situation will accelerate the growth of the segment.
The telemedicine industry is undergoing a technology revolution in India. Telemedicine is becoming a primary healthcare delivery channel. New telemedicine platforms and start-ups are evolving in India such as Phable, Practo, mfine, CallHealth, and Lybrate. The government of India such as the National Digital Health Mission is taking necessary steps through active policy formulation to develop a telemedicine ecosystem and increase its usage rate.
Telemedicine enables healthcare providers to visit patients virtually. The rising smartphone and internet penetration in rural areas, awareness about the availability of virtual visits as an alternative to physical consultations, escalating number of chronic diseases along with the need for better pre-and post-operative care, and access to affordable home monitoring equipment are the factors that are propelling the growth of telemedicine market in India.
Telemedicine has certain limitations such as miscommunication of symptoms by patients, misinterpretation and misdiagnosis of symptoms by physicians, and non-medical issues such as network problems, app usage, and cyberthreats, etc. Lack of digital infrastructure, lack of awareness and digital literacy, especially in rural areas, lack of specialized staff to diagnose illness virtually, need for regulation and framework are the challenges faced by the Indian telemedicine market.
There is a need to build a complete digital health ecosystem in India for seamless care and a need to automate parts of the telemedicine process, the COVID-19 phase has ramped up the telemedicine infrastructure and set up complete integrated solutions across India which create a lucrative opportunity for growth of Indian telemedicine market.
India is one of the top ten countries in the global telemedicine market. The early adoption of the regulatory framework will help the market segment grow rapidly. Telemedicine is a field that bridges the healthcare gap between rural India and urban India. In rural India, the use of medical facilities, expert opinions, and advanced medical services is limited, telemedicine acts as a primary healthcare provider to provide services of specialist doctors in rural India. During the COVID-19 pandemic, telemedicine can also help in reducing the burden on the tertiary hospitals by providing diagnosis and treatment to patients in their own geographical location and the patient will not be exposed to hospital visits.
There is a high investment from the private sector in the field of telemedicine and it has a bright future. India’s health tech industry is primarily driven by startup players rather than large corporations. Nevertheless, the industry players such as Practo and mFine, startups such as Meddo and Navia Lifecare have also implemented teleconsultations via voice and video facilities. The main purpose is to reduce the patients' visits to hospitals for non-emergency cases. For instance, Health tech AI startup MFine has raised $16m in a new funding round led by Heritas Capital with participation from the Singapore-based family office of Y’S Investment Pte Ltd. MFine plans to use this funding to triple its investment in AI development, mobile engineering, and device integration. Besides this, it will look into expanding its hospital network across the country and scaling the recently launched services such as delivering medicines, preventive health screenings, and diagnostic tests.
Some of the key players operating in the India telemedicine market: Practo, 1mg, CVS Health, Lybrate, Inc., NovaCura Tech health services (mFine), Netmeds Marketplace Ltd., Meta16labs Healthcare & Analytics Pvt., Ltd., TeleVital, Zoylo Digihealth Pvt. Ltd., and Rijuven (India).